RHHB.Y Share Price Performance
US$38.62
-1.21 (-3.04%)
Price US$38.62
Share PriceUS$38.62
RHHB.Y Community Narratives
There are no narratives available yet.
Recent RHHB.Y News & Updates
No updates
Roche Holding AG Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 11.09
- Gross Margin
- 74.79%
- Net Profit Margin
- 14.85%
- Debt/Equity Ratio
- 100.0%
Roche Holding AG Competitors
About RHHB.Y
- Founded
- 1896
- Employees
- 103249
- CEO
- WebsiteView website
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.
Swiss Market Performance
- 7 Days: 0.2%
- 3 Months: -0.7%
- 1 Year: 1.3%
- Year to Date: 2.5%
In the last week, the market has stayed flat, however the Financials sector stood out, gaining 3.5%. In line with that, the market has also been flat over the past year. Earnings are forecast to grow by 11% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading